Caverta 50 mg Ranbaxy

What Is Caverta 50 mg by Ranbaxy? Caverta 50 mg is a pharmaceutical-grade sildenafil citrate tablet manufactured by Ranbaxy, a well-established generic pharmaceutical producer. Sildenafil citrate is a selective inhibitor of phosphodiesterase type-5 (PDE5), an enzyme that degrades cyclic guanosine monophosphate (cGMP) in vascular smooth muscle tissue. By inhibiting PDE5, sildenafil prolongs cGMP signalling, producing vasodilatory effects that are extensively studied in cardiovascular and urological research models. Researchers examining PDE5 inhibition mechanisms will find Caverta 50 mg a well-characterised reference compound sourced from a recognised pharmaceutical manufacturer. Browse our full range of sexual health and research compounds at uksteroidshops.co.uk for a comprehensive selection of lab-grade materials. Research Applications and Investigative Context Sildenafil citrate has one of the most extensively documented pharmacological profiles among PDE5 inhibitors, making Caverta 50 mg a valuable compound for researchers investigating nitric oxide–cGMP signalling, endothelial function, and pulmonary arterial smooth muscle responses. Preclinical and clinical literature documents its selectivity for PDE5 over PDE3 (cardiac isoform), a property frequently examined in cardiovascular safety studies. Additionally, sildenafil’s interaction with the NO–cGMP axis makes it a relevant reference compound in studies of erectile tissue physiology, pulmonary hypertension models, and platelet aggregation research. Those studying oral bioavailability and first-pass hepatic metabolism may also find sildenafil a useful comparator compound. Researchers interested in complementary oral research agents may also wish to explore our oral steroids category for additional pharmacologically active reference materials. Product Specifications Caverta 50 mg Ranbaxy — Technical Specifications Parameter Detail Compound Sildenafil Citrate Brand Caverta (Ranbaxy) Strength 50 mg per tablet CAS Number 171599-83-0 Molecular Formula C₂₈H₃₈N₆O₁₁S Molecular Weight 666.74 g/mol Form Oral tablet Mechanism Selective PDE5 inhibitor Storage Room temperature, dry, away from direct light SKU EU14560 Researchers interested in vascular biology and pharmacology may also find value in reviewing our injectable steroids range, which includes additional reference compounds relevant to hormone-mediated vascular and metabolic pathways. For those specifically investigating PDE5 inhibitor pharmacokinetics, our curated Viagra (Sildenafil) category lists all available sildenafil-class compounds currently in stock. Compliance and Safety Notice Caverta 50 mg Ranbaxy is supplied strictly for research and educational purposes. This product is intended for laboratory investigation only and is not supplied for human consumption or therapeutic use. Purchasers must be aged 18 or over and must comply with all applicable local and national laws regarding the acquisition and handling of this compound. Nothing on this page constitutes medical advice or a recommendation for personal use. Always consult a qualified healthcare professional before handling pharmacologically active compounds.